Arcutis Biotherapeutics Inc
Ownership
Ownership Structure
Who owns Arcutis Biotherapeutics Inc (ARQT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 74.6% of the shares are freely tradable; institutional investors hold 110.2%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Suvretta Capital Management, LLC | 9.81 | 12,327,000 | +3.0 | 03/31/2026 |
| Frazier Life Sciences Management, L.P. | 7.86 | 9,874,511 | +0.0 | 03/31/2026 |
| BlackRock Inc | 7.32 | 9,200,411 | +1.1 | 03/31/2026 |
| Rubric Capital Management LP | 6.58 | 8,271,577 | +0.0 | 03/31/2026 |
| State Street Corp | 5.01 | 6,296,197 | +14.7 | 03/31/2026 |
| Polar Capital Holdings PLC | 4.51 | 5,666,940 | +2.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.88 | 4,871,536 | +0.0 | 03/31/2026 |
| Gilder Gagnon Howe & CO LLC | 3.42 | 4,304,010 | -3.4 | 03/31/2026 |
| Jennison Associates LLC | 3.36 | 4,219,058 | -15.3 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Polar Capital Biotech S Inc | 4.98 | 6,259,174 | +0.0 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Watanabe Todd | See Remarks | 717,203 | 19,005,880 $ | Aug 3, 2026 | direct |
| Burnett Patrick | See Remarks | 117,592 | 3,116,188 $ | Aug 19, 2026 | direct |
| Matsuda Masaru | See Remarks | 116,182 | 3,078,823 $ | Sep 8, 2026 | direct |
| Welgus Howard G. | Director | 36,475 | 966,588 $ | Aug 17, 2026 | direct |
| Curran Terrie | Director | 23,526 | 623,439 $ | Aug 27, 2026 | direct |
| Peetz Christopher | Director | 4,315 | 114,348 $ | Jul 15, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Matsuda Masaru | See Remarks | Sell | 9,989 | 25.03 | 249,986 |
| Aug 27, 2026 | Curran Terrie | Director | Sell | 27,052 | 25.03 | 677,095 |
| Aug 27, 2026 | Curran Terrie | Director | Other | 27,052 | 8.63 | 233,459 |
| Aug 27, 2026 | Curran Terrie | Director | Sell | 11,148 | 25.03 | 279,028 |
| Aug 27, 2026 | Curran Terrie | Director | Other | 11,148 | 7.51 | 83,721 |
| Aug 20, 2026 | Curran Terrie | Director | Sell | 1,072 | 26.04 | 27,912 |
| Aug 20, 2026 | Curran Terrie | Director | Other | 1,072 | 7.51 | 8,051 |
| Aug 19, 2026 | Burnett Patrick | See Remarks | Sell | 1,697 | 27.00 | 45,819 |
| Aug 17, 2026 | Welgus Howard G. | Director | Sell | 4,730 | 26.18 | 123,835 |
| Aug 17, 2026 | Welgus Howard G. | Director | Other | 2,255 | 8.63 | 19,461 |
| Aug 17, 2026 | Welgus Howard G. | Director | Other | 1,019 | 7.51 | 7,653 |
| Aug 17, 2026 | Welgus Howard G. | Director | Other | 822 | 6.52 | 5,361 |
| Aug 12, 2026 | Burnett Patrick | See Remarks | Sell | 6,700 | 26.08 | 174,767 |
| Aug 12, 2026 | Burnett Patrick | See Remarks | Other | 6,700 | 3.64 | 24,388 |
| Aug 11, 2026 | Burnett Patrick | See Remarks | Sell | 8,300 | 26.52 | 220,129 |
| Aug 11, 2026 | Burnett Patrick | See Remarks | Other | 8,300 | 3.64 | 30,212 |
| Aug 3, 2026 | Burnett Patrick | See Remarks | Sell | 955 | 26.12 | 24,942 |
| Aug 3, 2026 | Matsuda Masaru | See Remarks | Sell | 1,230 | 26.12 | 32,124 |
| Aug 3, 2026 | Watanabe Todd | See Remarks | Sell | 4,375 | 26.12 | 114,261 |
| Jul 15, 2026 | Peetz Christopher | Director | Other | 4,315 | 0.00 | – |
| Jul 15, 2026 | Welgus Howard G. | Director | Sell | 4,730 | 26.91 | 127,284 |
| Jul 15, 2026 | Welgus Howard G. | Director | Other | 2,255 | 8.63 | 19,461 |
| Jul 15, 2026 | Welgus Howard G. | Director | Other | 1,019 | 7.51 | 7,653 |
| Jul 15, 2026 | Welgus Howard G. | Director | Other | 822 | 6.52 | 5,361 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.